Perspective · 10 Sep 2026
Conference abstractPublished 26 Nov 2018
Low levels of natural antibodies against phosphorylcholine-a novel concept in autoimmunity
Karolinska Institutet, Nobels vag 1, Sweden
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Atherosclerosis is a chronic inflammatory disease process, which leads to cardiovascular disease (CVD) which is increased in rheumatic diseases, especially in systemic lupus erythematosus (SLE). IgM antibodies to phosphorylcholine (anti- PC) constitute a significant part of the circulating IgM pool. We reported that anti-PC is a protection marker for atherosclerosis and CVD, and applies also to rheumatic and autoimmune diseases. Material & Methods: We use a combination of ex vivo studies and cohort studies. Dendritic cells (DC) and T cells from patients with SLE, and from atherosclerotic plaques, are studied, and anti-PC is determined by ELISA. Results: Having low levels of anti-PC (below tertile or quartile) was associated with SLE, with CVD and atherosclerosis in SLE, and with being a non-responder to biologics in rheumatoid arthritis. Anti-PC promoted polarization of T cells from SLE patients into T regulatory cells, and from a lower level than among controls, T regs normalized in SLE patients after anti-PC exposure. Other potential underlying mechanisms include an anti-inflammatory property (inhibition of pro-inflammatory lipids which are raised in SLE); inhibition of uptake of oxidized LDL in macrophages; increased clearance by phagocytosis of dead cells. Anti-PC levels were very high in New Guinea among people living a traditional âÂ?Â?stone ageâÂ? life, and where rheumatic diseases and chronic inflammatory conditions are virtually unknown and also anti-PC was associated with some infectious agents there. Conclusion: Low anti-PC could contribute to development of autoimmune and rheumatic disease, in addition to atherosclerosis and CVD. One underlying cause could be lack of exposure to some microorganisms. These findings could have therapeutic implications, including immunization to raise anti-PC levels.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Johan Frostegard”
